Literature DB >> 21471230

Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors.

Richard J P Brown1, Paul J Peters, Catherine Caron, Maria Paz Gonzalez-Perez, Leanne Stones, Chiambah Ankghuambom, Kemebradikumo Pondei, C Patrick McClure, George Alemnji, Stephen Taylor, Paul M Sharp, Paul R Clapham, Jonathan K Ball.   

Abstract

HIV-1 circulates within an infected host as a genetically heterogeneous viral population. Viral intrahost diversity is shaped by substitutional evolution and recombination. Although many studies have speculated that recombination could have a significant impact on viral phenotype, this has never been definitively demonstrated. We report here phylogenetic and subsequent phenotypic analyses of envelope genes obtained from HIV-1 populations present in different anatomical compartments. Assessment of env compartmentalization from immunologically discrete tissues was assessed utilizing a single genome amplification approach, minimizing in vitro-generated artifacts. Genetic compartmentalization of variants was frequently observed. In addition, multiple incidences of intercompartment recombination, presumably facilitated by low-level migration of virus or infected cells between different anatomic sites and coinfection of susceptible cells by genetically divergent strains, were identified. These analyses demonstrate that intercompartment recombination is a fundamental evolutionary mechanism that helps to shape HIV-1 env intrahost diversity in natural infection. Analysis of the phenotypic consequences of these recombination events showed that genetic compartmentalization often correlates with phenotypic compartmentalization and that intercompartment recombination results in phenotype modulation. This represents definitive proof that recombination can generate novel combinations of phenotypic traits which differ subtly from those of parental strains, an important phenomenon that may have an impact on antiviral therapy and contribute to HIV-1 persistence in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471230      PMCID: PMC3126287          DOI: 10.1128/JVI.00131-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  89 in total

1.  Selection of HIV-1 genotypes by cultivation in different primary cells.

Authors:  H von Briesen; M Grez; H Ruppach; I Raudonat; R E Unger; K Becker; B Panhans; U Dietrich; H Rübsamen-Waigmann
Journal:  AIDS       Date:  1999-02-25       Impact factor: 4.177

2.  RDP2: recombination detection and analysis from sequence alignments.

Authors:  D P Martin; C Williamson; D Posada
Journal:  Bioinformatics       Date:  2004-09-17       Impact factor: 6.937

3.  MODELTEST: testing the model of DNA substitution.

Authors:  D Posada; K A Crandall
Journal:  Bioinformatics       Date:  1998       Impact factor: 6.937

4.  Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination.

Authors:  Sean Philpott; Harold Burger; Christos Tsoukas; Brian Foley; Kathryn Anastos; Christina Kitchen; Barbara Weiser
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Semen-specific genetic characteristics of human immunodeficiency virus type 1 env.

Authors:  Satish K Pillai; Benjamin Good; Sergei Kosakovsky Pond; Joseph K Wong; Matt C Strain; Douglas D Richman; Davey M Smith
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages.

Authors:  Brandon L Walter; Kathy Wehrly; Ronald Swanstrom; Emily Platt; David Kabat; Bruce Chesebro
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders.

Authors:  Isabella Abbate; Giuseppina Cappiello; Roberta Longo; Antonella Ursitti; Alberto Spanò; Silvia Calcaterra; Ferdinando Dianzani; Andrea Antinori; Maria R Capobianchi
Journal:  Infect Genet Evol       Date:  2004-12-07       Impact factor: 3.342

8.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.

Authors:  K S Lole; R C Bollinger; R S Paranjape; D Gadkari; S S Kulkarni; N G Novak; R Ingersoll; H W Sheppard; S C Ray
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.

Authors:  P D Kwong; R Wyatt; J Robinson; R W Sweet; J Sodroski; W A Hendrickson
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

View more
  35 in total

1.  Identifying recombination hot spots in the HIV-1 genome.

Authors:  Redmond P Smyth; Timothy E Schlub; Andrew J Grimm; Caryll Waugh; Paula Ellenberg; Abha Chopra; Simon Mallal; Deborah Cromer; Johnson Mak; Miles P Davenport
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

2.  Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

Authors:  Juan C Zapata; Marco Goicochea; Yuka Nadai; Lindsay M Eyzaguirre; Jean K Carr; Luke J Tallon; Lisa Sadzewicz; Garry Myers; Claire M Fraser; Qi Su; Mahmoud Djavani; Igor S Lukashevich; Maria S Salvato
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

3.  HIV-1 pathogenesis: the virus.

Authors:  Ronald Swanstrom; John Coffin
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

Review 4.  Viral diseases of the central nervous system.

Authors:  Phillip A Swanson; Dorian B McGavern
Journal:  Curr Opin Virol       Date:  2015-02-12       Impact factor: 7.090

5.  HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.

Authors:  Briana Quitadamo; Paul J Peters; Alexander Repik; Olivia O'Connell; Zhongming Mou; Matthew Koch; Mohan Somasundaran; Robin Brody; Katherine Luzuriaga; Aaron Wallace; Shixia Wang; Shan Lu; Sean McCauley; Jeremy Luban; Maria Duenas-Decamp; Maria Paz Gonzalez-Perez; Paul R Clapham
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

6.  Evidence for both Intermittent and Persistent Compartmentalization of HIV-1 in the Female Genital Tract.

Authors:  Batsirai M Mabvakure; Bronwen E Lambson; Kavisha Ramdayal; Lindi Masson; Dale Kitchin; Mushal Allam; Salim Abdool Karim; Carolyn Williamson; Jo-Ann Passmore; Darren P Martin; Cathrine Scheepers; Penny L Moore; Gordon W Harkins; Lynn Morris
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

7.  Human immunodeficiency virus infects human seminal vesicles in vitro and in vivo.

Authors:  Claire Deleage; Marina Moreau; Nathalie Rioux-Leclercq; Annick Ruffault; Bernard Jégou; Nathalie Dejucq-Rainsford
Journal:  Am J Pathol       Date:  2011-09-15       Impact factor: 4.307

Review 8.  The emergence of drug resistant HIV variants and novel anti-retroviral therapy.

Authors:  Koosha Paydary; Parisa Khaghani; Sahra Emamzadeh-Fard; Seyed Ahmad Seyed Alinaghi; Kazem Baesi
Journal:  Asian Pac J Trop Biomed       Date:  2013-07

9.  Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.

Authors:  Po-Jen Yen; Alon Herschhorn; Hillel Haim; Ignacio Salas; Christopher Gu; Joseph Sodroski; Dana Gabuzda
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

10.  Envelope gene evolution and HIV-1 neuropathogenesis.

Authors:  Fabián J Vázquez-Santiago; Vanessa Rivera-Amill
Journal:  J Neuroinfect Dis       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.